BIVID Projected Dividend Yield
BioVie Inc ( OTCBB : BIVID )BioVie is a clinical-stage company. Co. is engaged in the discovery, development, and commercialization of drug therapies. Co. is focused on developing and commercializing BIV201 (continuous infusion terlipressin), an approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of patients suffering from complications of liver cirrhosis due to hepatitis, nonalcoholic steatohepatitis, and alcoholism. 20 YEAR PERFORMANCE RESULTS |
BIVID Dividend History Detail BIVID Dividend News BIVID Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |